132 related articles for article (PubMed ID: 12168931)
1. The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.
Ben-Hur H; Cohen O; Schneider D; Gurevich P; Halperin R; Bala U; Mozes M; Zusman I
Anticancer Res; 2002; 22(2B):1231-8. PubMed ID: 12168931
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
Ben-Hur H; Mordechay E; Halperin R; Gurevich P; Zandbank J; Herper M; Zusman I
Oncol Rep; 2002; 9(5):977-80. PubMed ID: 12168058
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
4. Spectral morphometric characterization of breast carcinoma cells.
Barshack I; Kopolovic J; Malik Z; Rothmann C
Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
[TBL] [Abstract][Full Text] [Related]
5. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors.
Ben-Hur H; Gurevich P; Huszar M; Ben-Arie A; Berman V; Tendler Y; Zinder O; Tchanishev R; Gershon S; Mor G; Zaltsman Y; Kohen F; Zusman I
Eur J Gynaecol Oncol; 2000; 21(1):53-7. PubMed ID: 10726619
[TBL] [Abstract][Full Text] [Related]
7. The amount of surface HLA-I on T lymphocytes decreases in breast infiltrating ductal carcinoma patients.
Zhao S; Yang X; Lu N; Zhang Y; Li X; Li Y; Zhou Y; Wan F; Zou X
J Int Med Res; 2011; 39(2):508-13. PubMed ID: 21672354
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
9. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
Goff SL; Danforth DN
Clin Breast Cancer; 2021 Feb; 21(1):e63-e73. PubMed ID: 32893093
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in a fibroadenoma.
Sarela AI; Madvanur AA; Soonawala ZF; Shah HK; Pandit AA; Samsi AB
J Postgrad Med; 1995; 41(1):19-20. PubMed ID: 10740697
[TBL] [Abstract][Full Text] [Related]
11. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.
Kostianets O; Antoniuk S; Filonenko V; Kiyamova R
Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
Lee AH; Happerfield LC; Millis RR; Bobrow LG
Br J Cancer; 1996 Sep; 74(5):796-801. PubMed ID: 8795584
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast.
Chen LY; Tsang JY; Ni YB; Chan SK; Chan KF; Zhang S; Tse GM
J Clin Pathol; 2016 Jun; 69(6):527-32. PubMed ID: 26582743
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
16. Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast.
Ladekarl M; Sørensen FB
APMIS; 1993 Dec; 101(12):895-903. PubMed ID: 8110444
[TBL] [Abstract][Full Text] [Related]
17. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas.
Nzula S; Going JJ; Stott DI
Cancer Res; 2003 Jun; 63(12):3275-80. PubMed ID: 12810659
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
Zhu S; Lin J; Qiao G; Xu Y; Zou H
Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
